Priority Date: 29.11.11 (US 201161564760P)

2-PHENYLAMINOPYRIMIDINE DERIVATIVES AS KINASE LRRK2 MODULATORS FOR THE TREATMENT OF PARKINSON'S DISEASE

  • Application ID: EP12791761
  • Status: GRANT OF PATENT INTENDED

Applicants

Technology company logo small
Technology Company
Technology company logo small
Technology Company

Attorneys

operating since 1890
Headquarter in London and 4 offices
active in Legal Services
no operation time available
Technology Company

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Mewburn Ellis LLP is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 188 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 29.11.2011 - Priority Date (US 201161564760P)
  • 06.06.2013 - Publication A1 (WO2013079494)
  • 08.10.2014 - Publication A1 (EP2785699)